Cardiovascular Safety Profile of Dapoxetine during the Premarketing Evaluation

The cardiovascular safety profile of dapoxetine, a novel selective serotonin reuptake inhibitor (SSRI) developed as an on-demand oral treatment for premature ejaculation (PE) in men, is evaluated. The cardiovascular assessment of dapoxetine was conducted throughout all stages of drug development, wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kowey, Peter R., Mudumbi, Ramagopal V., Aquilina, Joseph W., DiBattiste, Peter M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2012
Materias:
Current Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3585760/
https://www.ncbi.nlm.nih.gov/pubmed/21410293
http://dx.doi.org/10.2165/11587660-000000000-00000

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3585760/
https://www.ncbi.nlm.nih.gov/pubmed/21410293
http://dx.doi.org/10.2165/11587660-000000000-00000

Ejemplares similares